Xiangxue Pharmaceutical Co Stock | 300147.SZ | CNE100000Y92 |

Date	Xiangxue Pharmaceutical Co Price
9/11/2024	6.61 undefined
9/10/2024	6.69 undefined
9/9/2024	7.23 undefined
9/6/2024	7.07 undefined
9/5/2024	7.26 undefined
9/4/2024	6.80 undefined
9/3/2024	6.68 undefined
9/2/2024	7.29 undefined
8/30/2024	7.05 undefined
8/29/2024	6.81 undefined
8/28/2024	6.73 undefined
8/27/2024	6.84 undefined
8/26/2024	6.89 undefined
8/23/2024	8.23 undefined
8/22/2024	8.03 undefined
8/21/2024	8.04 undefined
8/20/2024	8.05 undefined
8/19/2024	8.02 undefined
8/16/2024	8.85 undefined
8/15/2024	10.55 undefined

Date	Xiangxue Pharmaceutical Co Revenue	Xiangxue Pharmaceutical Co EBIT	Xiangxue Pharmaceutical Co Net Income
2023	2.3 B undefined	39.74 M undefined	-388.96 M undefined
2022	2.19 B undefined	-181.89 M undefined	-533.16 M undefined
2021	2.97 B undefined	-2.24 M undefined	-688.47 M undefined
2020	3.07 B undefined	389.3 M undefined	98.4 M undefined
2019	2.79 B undefined	263.4 M undefined	76.5 M undefined
2018	2.5 B undefined	317.2 M undefined	56.4 M undefined
2017	2.19 B undefined	115.3 M undefined	65.9 M undefined
2016	1.86 B undefined	118.1 M undefined	66 M undefined
2015	1.46 B undefined	217.4 M undefined	177.3 M undefined
2014	1.52 B undefined	255.3 M undefined	196.8 M undefined
2013	1.26 B undefined	232.1 M undefined	158.2 M undefined
2012	801 M undefined	147 M undefined	107.2 M undefined
2011	616.1 M undefined	102.2 M undefined	83.5 M undefined
2010	513.4 M undefined	101.3 M undefined	74.2 M undefined
2009	378.6 M undefined	71.4 M undefined	51 M undefined
2008	294.8 M undefined	41.7 M undefined	35.9 M undefined
2007	258.3 M undefined	37.1 M undefined	30.8 M undefined

	Revenue	EBIT	Net Income
2007	258.3 M CNY	37.1 M CNY	30.8 M CNY
2008	294.8 M CNY	41.7 M CNY	35.9 M CNY
2009	378.6 M CNY	71.4 M CNY	51 M CNY
2010	513.4 M CNY	101.3 M CNY	74.2 M CNY
2011	616.1 M CNY	102.2 M CNY	83.5 M CNY
2012	801 M CNY	147 M CNY	107.2 M CNY
2013	1.26 B CNY	232.1 M CNY	158.2 M CNY
2014	1.52 B CNY	255.3 M CNY	196.8 M CNY
2015	1.46 B CNY	217.4 M CNY	177.3 M CNY
2016	1.86 B CNY	118.1 M CNY	66 M CNY
2017	2.19 B CNY	115.3 M CNY	65.9 M CNY
2018	2.5 B CNY	317.2 M CNY	56.4 M CNY
2019	2.79 B CNY	263.4 M CNY	76.5 M CNY
2020	3.07 B CNY	389.3 M CNY	98.4 M CNY
2021	2.97 B CNY	-2.24 M CNY	-688.47 M CNY
2022	2.19 B CNY	-181.89 M CNY	-533.16 M CNY
2023	2.3 B CNY	39.74 M CNY	-388.96 M CNY

2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
0.26	0.29	0.38	0.51	0.62	0.8	1.26	1.52	1.46	1.86	2.19	2.5	2.79	3.07	2.97	2.19	2.3
-	13.95	28.57	35.71	20.08	30.03	57.43	20.86	-3.94	27.19	17.45	14.49	11.26	10.27	-3.32	-26.36	5.12
46.12	51.02	50.53	46.20	45.94	47.69	41.00	41.60	42.62	31.53	29.49	36.46	31.59	32.29	24.95	24.28	32.32
119	150	191	237	283	382	517	634	624	587	645	913	880	992	741	531	743
37	41	71	101	102	147	232	255	217	118	115	317	263	389	-2	-181	39
14.34	13.95	18.78	19.69	16.56	18.35	18.40	16.73	14.82	6.34	5.26	12.66	9.44	12.66	-0.07	-8.28	1.70
30	35	51	74	83	107	158	196	177	66	65	56	76	98	-688	-533	-388
-	16.67	45.71	45.10	12.16	28.92	47.66	24.05	-9.69	-62.71	-1.52	-13.85	35.71	28.95	-802.04	-22.53	-27.20
396.9	396.9	396.9	450.8	602.7	608.6	615.6	609.6	661.5	660.2	661.5	661.5	637.6	661.5	661.36	658.22	661.28
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2021	2022	2023

0.04	0.04	0.09	1.15	0.79	1.29	0.77	0.33	0.68	0.86	2.01	0.93	0.36	0.5	0.37	0.34	0.13	0.14
0.01	0.01	0.04	0.05	0.06	0.12	0.32	0.4	0.52	0.8	0.81	0.84	0.95	1.04	1.22	1.1	0.6	0.7
0	0.02	0.03	0.04	0.04	0.06	0.09	0.11	0.16	0.36	1.4	1.28	0.56	0.99	0.35	0.57	0.27	0.21
19.8	23.6	30.2	54.2	89.4	128.7	224.6	284.3	341.7	503.1	504.5	590.1	756.4	839.8	761.46	761.46	467.07	411.3
21.1	22.1	32.9	34.4	72.6	90	97.3	123.4	427.7	463.8	149.1	285.3	474.3	353.6	466.92	313.47	233.67	362.64
0.1	0.12	0.22	1.34	1.05	1.69	1.5	1.25	2.13	2.98	4.87	3.92	3.1	3.72	3.16	3.09	1.69	1.82
0.4	0.36	0.41	0.44	0.69	1.03	1.3	1.48	1.62	2.87	2.4	2.68	3.46	3.66	5.96	6.01	4.82	4.64
1.8	1.6	1.5	1.4	1.4	1.3	18.9	168.5	157.2	269.6	334.9	366.2	444.2	668.3	270.21	521.94	486.39	193.16
0	0	0	0	0	0	0	0	0	0	0	0	0	0	346.04	0	76.47	0
0.05	0.07	0.07	0.07	0.11	0.16	0.22	0.24	0.3	0.4	0.56	0.78	0.72	0.97	1.03	1.43	1.37	1.36
1.4	1.3	1.3	1.2	66.7	66.7	423.7	422.5	422.5	634.5	646.7	644.7	626.6	626.6	266.6	266.6	199.72	199.72
0.8	1.2	1	1	3	3.8	11.5	29.4	21.9	836.5	427.1	234.4	108.8	127.3	318	67.03	71.07	68.73
0.45	0.44	0.48	0.51	0.87	1.26	1.98	2.34	2.52	5.01	4.37	4.71	5.36	6.06	8.19	8.29	7.03	6.46
0.55	0.55	0.7	1.85	1.92	2.95	3.47	3.59	4.65	7.99	9.24	8.63	8.46	9.78	11.35	11.38	8.72	8.28

81	81	92	123	246	301	392.1	509.6	661.5	661.5	661.5	661.5	661.5	661.5	661.36	661.36	661.28	661.28
0.01	0.01	0.08	1.06	0.93	0.91	0.84	0.73	2.13	2.13	2.13	2.13	2.09	2.15	2.15	2.15	2.15	2.15
90.8	94.3	145.2	169.2	215.8	273.7	371.6	505.7	614.2	600.9	666.8	703.4	801.2	825.7	138.42	138.42	-493.1	-882.06
-0.5	-0.9	-0.8	-0.9	-1	-1	-1.2	-3.6	-2.4	-0.1	-0.7	3.3	-36.5	4.2	814.29	4.11	6.05	6.27
0	0	0	0	0	0	0	0	0	0	0	0	0	0	-2.04	-2.04	-11.24	-4.58
0.18	0.18	0.32	1.35	1.39	1.48	1.61	1.74	3.41	3.4	3.46	3.5	3.52	3.64	3.76	2.95	2.32	1.93
0.04	0.07	0.06	0.07	0.07	0.08	0.15	0.18	0.21	0.42	0.41	0.43	0.57	0.68	1.12	1.11	0.97	1.08
4.7	6.8	4.3	6.9	8.1	31	31.3	31.8	30.7	45.7	55.5	54.2	42.7	51.9	72.82	79	121.27	128
0.04	0.05	0.07	0.06	0.05	0.05	0.35	0.22	0.25	1.14	1.07	0.4	0.36	0.37	2.83	1.82	1.57	1.72
0.04	0.12	0.13	0.24	0.15	0.51	0.42	0.63	0.07	1.2	1.7	1.48	1.95	3.15	2.47	3.48	2.49	1.89
12.5	25	25	25	12.5	40	60	80	0	500.1	0	852.9	331.2	134	450.5	450.5	79.97	343.95
0.14	0.27	0.29	0.4	0.29	0.71	1.02	1.14	0.56	3.3	3.24	3.22	3.26	4.38	6.94	6.94	5.23	5.16
0.09	0.06	0.04	0.04	0.18	0.67	0.72	0.54	0.5	0.75	1.82	1.31	0.94	0.95	0.53	0.53	0.45	0.59
0	0	0	0	0	0	0	0	0	0	0	14.5	0	0	3.73	3.73	6.62	9.46
138	26.5	26.7	29.7	27.7	30.4	30.7	42.8	43.2	249.2	299.8	68	148.7	198.2	-6,347.27	143.51	230.41	205.35
0.23	0.09	0.07	0.07	0.21	0.71	0.75	0.58	0.54	1	2.12	1.39	1.09	1.15	-5.81	0.68	0.69	0.81
0.36	0.36	0.36	0.48	0.5	1.41	1.76	1.72	1.11	4.3	5.36	4.61	4.35	5.53	1.13	7.62	5.92	5.97
0.54	0.54	0.68	1.82	1.9	2.9	3.37	3.46	4.51	7.7	8.82	8.12	7.87	9.16	4.9	10.58	8.24	7.9

2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2021	2022
0	0	0	0	0	0	0	0	0	0	0	0	0	0	-688	0	-533
0	0	0	0	0	0	0	0	0	0	0	0	0	0	188	0	238
0	0	0	0	0	0	0	0	0	0	0	0	0	0	5	0	-16
-29	-75	-91	-86	-113	-222	-181	-386	-322	-487	-365	-566	-491	-377	118	-657	-436
0	0	0	0	0	0	0	0	0	0	0	0	0	0	662	0	326
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
-29	-34	-42	-54	-72	-75	-123	-117	-130	-135	-115	-105	-90	-111	116	-116	-65
138	55	46	45	29	118	328	165	159	198	109	91	83	257	257	257	227
-144	-137	-52	-56	-230	-418	-318	-243	-277	-1,966	-777	-495	-661	-707	-562	-562	-367
-93	-82	-52	-56	-368	-451	-578	-503	-612	-2,569	-673	219	848	-1,238	-112	-112	379
0.05	0.05	0	0	-0.14	-0.03	-0.26	-0.26	-0.34	-0.6	0.1	0.72	1.51	-0.53	0.45	0.45	0.75
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0.01	0.02	0.03	0.12	0.01	0.86	-0.16	0.04	-0.63	2.34	1.12	-0.53	-0.9	1.2	-0.27	-0.68	-0.49
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
-0.01	0.01	0.06	1.07	-0.02	0.84	-0.29	-0.11	0.79	2.22	0.96	-0.76	-1.03	1.12	-0.45	-0.45	-0.65
-0	0.04	0.05	1.01	0.02	0.06	0.02	-0	1.56	0.03	0.02	-0.02	0.11	0.13	0.04	0.45	0.02
-17	-42	-11	-65	-54	-80	-147	-150	-135	-157	-172	-207	-239	-204	-216	-216	-175
0.23	0.15	0.24	1.24	-0.15	0.92	0.09	0.22	0.95	0.67	0.99	0.32	0.56	0.89	0.73	0.73	0.68
-6.7	-82	-6.7	-11.4	-201.1	-299.2	9.9	-78.3	-117.1	-1,767.5	-668.4	-404.3	-578.1	-450.2	-305.18	-305.18	-139.89
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Xiangxue Pharmaceutical Co Gross margin	Xiangxue Pharmaceutical Co Profit margin	Xiangxue Pharmaceutical Co EBIT margin	Xiangxue Pharmaceutical Co Profit margin
2023	32.33 %	1.73 %	-16.92 %
2022	24.32 %	-8.32 %	-24.38 %
2021	24.96 %	-0.08 %	-23.18 %
2020	32.31 %	12.67 %	3.2 %
2019	31.61 %	9.45 %	2.75 %
2018	36.46 %	12.67 %	2.25 %
2017	29.5 %	5.27 %	3.01 %
2016	31.52 %	6.34 %	3.54 %
2015	42.64 %	14.84 %	12.11 %
2014	41.63 %	16.75 %	12.91 %
2013	41.06 %	18.4 %	12.54 %
2012	47.73 %	18.35 %	13.38 %
2011	46.03 %	16.59 %	13.55 %
2010	46.3 %	19.73 %	14.45 %
2009	50.45 %	18.86 %	13.47 %
2008	51.15 %	14.15 %	12.18 %
2007	46.3 %	14.36 %	11.92 %

	Gross margin	EBIT margin	Profit margin
2007	46.3 %	14.36 %	11.92 %
2008	51.15 %	14.15 %	12.18 %
2009	50.45 %	18.86 %	13.47 %
2010	46.3 %	19.73 %	14.45 %
2011	46.03 %	16.59 %	13.55 %
2012	47.73 %	18.35 %	13.38 %
2013	41.06 %	18.4 %	12.54 %
2014	41.63 %	16.75 %	12.91 %
2015	42.64 %	14.84 %	12.11 %
2016	31.52 %	6.34 %	3.54 %
2017	29.5 %	5.27 %	3.01 %
2018	36.46 %	12.67 %	2.25 %
2019	31.61 %	9.45 %	2.75 %
2020	32.31 %	12.67 %	3.2 %
2021	24.96 %	-0.08 %	-23.18 %
2022	24.32 %	-8.32 %	-24.38 %
2023	32.33 %	1.73 %	-16.92 %

Date	Xiangxue Pharmaceutical Co Sales per Share	Xiangxue Pharmaceutical Co EBIT per share	Xiangxue Pharmaceutical Co Earnings per Share
2023	3.48 undefined	0.06 undefined	-0.59 undefined
2022	3.32 undefined	-0.28 undefined	-0.81 undefined
2021	4.49 undefined	-0 undefined	-1.04 undefined
2020	4.64 undefined	0.59 undefined	0.15 undefined
2019	4.37 undefined	0.41 undefined	0.12 undefined
2018	3.79 undefined	0.48 undefined	0.09 undefined
2017	3.31 undefined	0.17 undefined	0.1 undefined
2016	2.82 undefined	0.18 undefined	0.1 undefined
2015	2.21 undefined	0.33 undefined	0.27 undefined
2014	2.5 undefined	0.42 undefined	0.32 undefined
2013	2.05 undefined	0.38 undefined	0.26 undefined
2012	1.32 undefined	0.24 undefined	0.18 undefined
2011	1.02 undefined	0.17 undefined	0.14 undefined
2010	1.14 undefined	0.22 undefined	0.16 undefined
2009	0.95 undefined	0.18 undefined	0.13 undefined
2008	0.74 undefined	0.11 undefined	0.09 undefined
2007	0.65 undefined	0.09 undefined	0.08 undefined

	Sales per Share	EBIT per share	Earnings per Share
2007	0.65 CNY	0.09 CNY	0.08 CNY
2008	0.74 CNY	0.11 CNY	0.09 CNY
2009	0.95 CNY	0.18 CNY	0.13 CNY
2010	1.14 CNY	0.22 CNY	0.16 CNY
2011	1.02 CNY	0.17 CNY	0.14 CNY
2012	1.32 CNY	0.24 CNY	0.18 CNY
2013	2.05 CNY	0.38 CNY	0.26 CNY
2014	2.5 CNY	0.42 CNY	0.32 CNY
2015	2.21 CNY	0.33 CNY	0.27 CNY
2016	2.82 CNY	0.18 CNY	0.1 CNY
2017	3.31 CNY	0.17 CNY	0.1 CNY
2018	3.79 CNY	0.48 CNY	0.09 CNY
2019	4.37 CNY	0.41 CNY	0.12 CNY
2020	4.64 CNY	0.59 CNY	0.15 CNY
2021	4.49 CNY	-0 CNY	-1.04 CNY
2022	3.32 CNY	-0.28 CNY	-0.81 CNY
2023	3.48 CNY	0.06 CNY	-0.59 CNY

	Number of stocks
2007	396.9 M Aktien
2008	396.9 M Aktien
2009	396.9 M Aktien
2010	450.8 M Aktien
2011	602.7 M Aktien
2012	608.6 M Aktien
2013	615.6 M Aktien
2014	609.6 M Aktien
2015	661.5 M Aktien
2016	660.2 M Aktien
2017	661.5 M Aktien
2018	661.5 M Aktien
2019	637.6 M Aktien
2020	661.5 M Aktien
2021	661.36 M Aktien
2022	658.22 M Aktien
2023	661.28 M Aktien

Date	Xiangxue Pharmaceutical Co Dividend
2020	0.05 undefined
2019	0.03 undefined
2018	0.03 undefined
2016	0.12 undefined
2015	0.11 undefined
2014	0.1 undefined
2013	0.12 undefined
2012	0.1 undefined
2011	0.07 undefined

	Dividend	Dividend (Estimate)
2007	0 CNY	0 CNY
2008	0 CNY	0 CNY
2009	0 CNY	0 CNY
2010	0 CNY	0 CNY
2011	0.07 CNY	0 CNY
2012	0.1 CNY	0 CNY
2013	0.12 CNY	0 CNY
2014	0.1 CNY	0 CNY
2015	0.11 CNY	0 CNY
2016	0.12 CNY	0 CNY
2017	0 CNY	0 CNY
2018	0.03 CNY	0 CNY
2019	0.03 CNY	0 CNY
2020	0.05 CNY	0 CNY
2021	0 CNY	0 CNY
2022	0 CNY	0 CNY
2023	0 CNY	0 CNY

Date	Xiangxue Pharmaceutical Co Payout ratio
2023	30.5 %
2022	29.95 %
2021	30.86 %
2020	30.67 %
2019	28.33 %
2018	33.59 %
2017	30.86 %
2016	120 %
2015	41.39 %
2014	31.84 %
2013	45.5 %
2012	54.78 %
2011	52.86 %
2010	30.86 %
2009	30.86 %
2008	30.86 %
2007	30.86 %

	Payout ratio
2007	30.86 %
2008	30.86 %
2009	30.86 %
2010	30.86 %
2011	52.86 %
2012	54.78 %
2013	45.5 %
2014	31.84 %
2015	41.39 %
2016	120 %
2017	30.86 %
2018	33.59 %
2019	28.33 %
2020	30.67 %
2021	30.86 %
2022	29.95 %
2023	30.5 %

Date	EPS Estimate	EPS Actual	Quarterly report
6/30/2015	0.18	0.1 (-44.99 %)	2015 Q2
12/31/2014	0.16	0.07 (-53.09 %)	2014 Q4
9/30/2014	0.18	0.1 (-43.43 %)	2014 Q3
6/30/2014	0.15	0.11 (-24.1 %)	2014 Q2
12/31/2013	0.08	0.08 (7.22 %)	2013 Q4
9/30/2013	0.1	0.08 (-14.23 %)	2013 Q3
6/30/2013	0.09	0.04 (-49.12 %)	2013 Q2
12/31/2012	0.12	0.04 (-61.34 %)	2012 Q4

%	Name	Stocks	Change	Date
4.07340 %	Guangzhou Luogang Water Supply Co., Ltd.	26,832,260	0	9/30/2023
22.68191 %	Guangzhou Kunlun Investment Co., Ltd.	149,409,921	0	9/30/2023
0.92393 %	CITIC Securities Co., Ltd. (Asset Management)	6,086,098	2,766,802	9/30/2023
0.61748 %	Liu (Wuxiong)	4,067,483	21,700	9/30/2023
0.38010 %	Ye (Xiao Zhao)	2,503,800	0	9/30/2023
0.36133 %	Liao (Tingbin)	2,380,158	46,000	9/30/2023
0.30704 %	China Universal Asset Management Co., Ltd.	2,022,500	25,000	9/30/2023
0.23024 %	Huang (Xueying)	1,516,660	18,000	9/30/2023
0.18958 %	China Southern Asset Management Co. Ltd.	1,248,800	1,248,800	6/30/2023
0.15975 %	Penghua Fund Management Co., Ltd.	1,052,300	367,200	6/30/2023
0.07197 %	GF Fund Management Co., Ltd.	474,100	-361,800	12/31/2023
0.06992 %	The Vanguard Group, Inc.	460,600	0	3/31/2024
0.05983 %	Zeng (Lun)	394,137	0	6/30/2023
0.04642 %	Kang (Zhiying)	305,787	0	6/30/2023
0.03757 %	Huang (Weihua)	247,484	0	6/30/2023
0.03062 %	Xu (Li)	201,701	0	6/30/2023
0.02752 %	Mo (Ziyu)	181,255	0	6/30/2023
0.02517 %	Huatai-PineBridge Fund Management Co., Ltd.	165,800	23,500	6/30/2023
0.02020 %	Tan (Wenhui)	133,031	0	6/30/2023
0.01391 %	Hwabao WP Fund Management Co., Ltd.	91,600	91,600	6/30/2023
0.01199 %	Yinhua Fund Management Co., Ltd.	79,000	79,000	6/30/2023
0.01087 %	Tianhong Asset Management Co., Ltd.	71,600	71,600	6/30/2023
0.00911 %	Chen (Wenjin)	60,000	0	6/30/2023
0.00436 %	INVESCO Great Wall Fund Management Co. Ltd.	28,700	28,700	6/30/2023
0.00422 %	Shanghai Haitong Securities Asset Management Ltd.	27,800	-15,500	12/31/2023
0.00228 %	Niu (Xiaoyan)	15,000	0	6/30/2023
0.00188 %	Sealand Securities Co., Ltd.	12,400	-69,700	6/30/2023
0.00035 %	Vanguard Investments Australia Ltd.	2,277	4	2/29/2024
0.00014 %	Lion Fund Management Co., Ltd.	900	900	6/30/2023
0 %	China Huarong Asset Management Co., Ltd.	0	-60,000	6/30/2023
0 %	Rongtong Fund Management Co., Ltd.	0	-11,200	12/31/2023

Name	Relationship	Two-week correlation	One-month correlation	Three-Month Correlation	Six-Month Correlation	One Year Correlation	Two-Year Correlation
China Meheco Group A	SupplierCustomer	0,87	0,75	0,45	0,24	0,12	0,10
Zhangzhou Pientzehuang A	SupplierCustomer	0,40	0,24	0,31	0,01	0,04	-0,68
Guangzhou Baiyunshan H	SupplierCustomer	0,30	0,49	0,11	0,45	0,61	0,06
Athenex	SupplierCustomer	-0,32	-0,45	0,80	0,14	0,38	0,85

What values and corporate philosophy does Xiangxue Pharmaceutical Co represent?

Xiangxue Pharmaceutical Co Ltd represents values of innovation, integrity, and sustainability in the pharmaceutical industry. With a strong corporate philosophy focused on research and development, Xiangxue Pharmaceutical strives to provide high-quality and affordable healthcare solutions to improve the lives of people globally. The company's commitment to technological advancements and scientific excellence enables them to develop cutting-edge pharmaceutical products and treatments. Xiangxue Pharmaceutical embraces a customer-centric approach, ensuring the well-being of patients and addressing unmet medical needs. By adhering to ethical business practices and promoting social responsibility, Xiangxue Pharmaceutical serves as a trusted partner in the healthcare sector.

In which countries and regions is Xiangxue Pharmaceutical Co primarily present?

Xiangxue Pharmaceutical Co Ltd is primarily present in China.

What significant milestones has the company Xiangxue Pharmaceutical Co achieved?

Xiangxue Pharmaceutical Co Ltd has achieved several significant milestones. The company has successfully developed and launched a range of innovative pharmaceutical products, gaining recognition within the industry. Xiangxue Pharmaceutical Co Ltd has also established strategic partnerships with leading international pharmaceutical companies, expanding its global reach and collaboration opportunities. Additionally, the company has shown consistent growth with its financial performance, demonstrating strong market presence and investor confidence. Overall, Xiangxue Pharmaceutical Co Ltd has made notable advancements, solidifying its position as a prominent player in the pharmaceutical sector.

What is the history and background of the company Xiangxue Pharmaceutical Co?

Xiangxue Pharmaceutical Co Ltd is a leading Chinese pharmaceutical company with a rich history and background. Founded in 1986, the company has grown into a renowned player in the healthcare industry. Xiangxue Pharmaceutical focuses on research, development, manufacturing, and marketing of innovative drugs, particularly in the fields of antibiotics, anti-tumor agents, and cardiovascular drugs. With its commitment to quality and innovation, the company has gained recognition both domestically and internationally. Xiangxue Pharmaceutical's dedication to improving human health and providing cutting-edge medical solutions sets it apart in the pharmaceutical sector.

Who are the main competitors of Xiangxue Pharmaceutical Co in the market?

The main competitors of Xiangxue Pharmaceutical Co Ltd in the market include companies such as Jiangsu Hengrui Medicine Co Ltd, Shanghai Fosun Pharmaceutical Group Co Ltd, and Beijing SL Pharmaceutical Co Ltd. These companies play a significant role in the pharmaceutical industry and compete with Xiangxue Pharmaceutical Co Ltd in terms of product offerings, market share, and innovation. It is essential for Xiangxue Pharmaceutical Co Ltd to continuously evaluate and differentiate its products and services to maintain a competitive edge with these prominent market players.

In which industries is Xiangxue Pharmaceutical Co primarily active?

Xiangxue Pharmaceutical Co Ltd is primarily active in the pharmaceutical industry. With a focus on research, development, manufacturing, and distribution of pharmaceutical products, Xiangxue Pharmaceutical plays a pivotal role in improving healthcare outcomes. Their expertise spans across various therapeutic areas, including cardiovascular, respiratory, gastrointestinal, and geriatric medicines. By continuously innovating and adhering to strict quality standards, Xiangxue Pharmaceutical strives to deliver safe and effective treatments to patients worldwide. With their strong presence in the pharmaceutical sector, Xiangxue Pharmaceutical remains committed to advancing healthcare and making a positive impact on people's lives.

What is the business model of Xiangxue Pharmaceutical Co?

The business model of Xiangxue Pharmaceutical Co Ltd revolves around the research, development, manufacturing, and sales of pharmaceutical products. As a leading pharmaceutical company, Xiangxue Pharmaceutical focuses on areas such as innovative drug development, generics, and biological products. The company's business model emphasizes a comprehensive approach to healthcare, including both traditional Chinese medicine and Western medicine. Xiangxue Pharmaceutical Co Ltd seeks to provide high-quality, affordable medications and medical solutions to improve public health.

What is the P/E ratio of Xiangxue Pharmaceutical Co 2024?

The P/E ratio cannot be calculated for Xiangxue Pharmaceutical Co at the moment.

What is the P/S ratio of Xiangxue Pharmaceutical Co 2024?

The P/S cannot be calculated for Xiangxue Pharmaceutical Co currently.

What is the AlleAktien quality score of Xiangxue Pharmaceutical Co?

The AlleAktien quality score for Xiangxue Pharmaceutical Co is 2/10.

What is the revenue of Xiangxue Pharmaceutical Co 2024?

The revenue cannot currently be calculated for Xiangxue Pharmaceutical Co.

How high is the profit of Xiangxue Pharmaceutical Co 2024?

The profit cannot currently be calculated for Xiangxue Pharmaceutical Co.

What is the business model of Xiangxue Pharmaceutical Co

Xiangxue Pharmaceutical Co Ltd is a Chinese company that specializes in the manufacturing and sale of pharmaceuticals and health products. The company was founded in 1997 and has been listed on the Shanghai Stock Exchange since 2003. The business model of Xiangxue Pharmaceutical includes several divisions, including the development, manufacturing, and marketing of pharmaceutical products, natural remedies, as well as dietary supplements and medical devices. The company produces a variety of drugs, including antibiotics, antiviral medications, drugs for the treatment of cancer and cardiovascular diseases. In addition, Xiangxue Pharmaceutical is also involved in research and development and has introduced several groundbreaking products to the market in recent years. An example is the medication "XKS," which is used for the treatment of liver diseases. It was developed by Xiangxue Pharmaceutical and is the first Chinese drug to be approved by the European Medicines Agency. In the field of natural health products, the company offers an extensive range of products, including herbal extracts, traditional Chinese medicine products, and other natural remedies. These products are distributed in China and internationally and are popular among consumers seeking a natural alternative to traditional Western medicine. Xiangxue Pharmaceutical also utilizes advanced technologies to produce innovative and effective products. The company continuously invests in research and development and collaborates closely with universities and research institutions to develop new products and technologies. The company aims to be a leader in the field of modern medicine and natural health products in the Chinese and international markets. To achieve this goal, Xiangxue Pharmaceutical has established a strong presence in the market and continuously works on improving its business operations. Overall, Xiangxue Pharmaceutical's business model is well positioned to succeed in the Chinese and international markets. By combining innovative products, advanced technology, and effective marketing, the company has gained a strong position in the healthcare market and is expected to continue to expand in the future.

What is the Xiangxue Pharmaceutical Co dividend?

Xiangxue Pharmaceutical Co pays a dividend of 0 CNY distributed over payouts per year.

How often does Xiangxue Pharmaceutical Co pay dividends?

The dividend cannot currently be calculated for Xiangxue Pharmaceutical Co or the company does not pay out a dividend.

What is the Xiangxue Pharmaceutical Co ISIN?

The ISIN of Xiangxue Pharmaceutical Co is CNE100000Y92.

What is the Xiangxue Pharmaceutical Co ticker?

The ticker of Xiangxue Pharmaceutical Co is 300147.SZ.

How much dividend does Xiangxue Pharmaceutical Co pay?

Over the past 12 months, Xiangxue Pharmaceutical Co paid a dividend of 0.05 CNY . This corresponds to a dividend yield of about 0.7 %. For the coming 12 months, Xiangxue Pharmaceutical Co is expected to pay a dividend of 0 CNY.

What is the dividend yield of Xiangxue Pharmaceutical Co?

The current dividend yield of Xiangxue Pharmaceutical Co is 0.7 %.

When does Xiangxue Pharmaceutical Co pay dividends?

Xiangxue Pharmaceutical Co pays a quarterly dividend. This is distributed in the months of July, July, September, July.

How secure is the dividend of Xiangxue Pharmaceutical Co?

Xiangxue Pharmaceutical Co paid dividends every year for the past 0 years.

What is the dividend of Xiangxue Pharmaceutical Co?

For the upcoming 12 months, dividends amounting to 0 CNY are expected. This corresponds to a dividend yield of 0 %.

In which sector is Xiangxue Pharmaceutical Co located?

Xiangxue Pharmaceutical Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Xiangxue Pharmaceutical Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Xiangxue Pharmaceutical Co from 6/23/2020 amounting to 0.046 CNY, you needed to have the stock in your portfolio before the ex-date on 6/23/2020.

When did Xiangxue Pharmaceutical Co pay the last dividend?

The last dividend was paid out on 6/23/2020.

What was the dividend of Xiangxue Pharmaceutical Co in the year 2023?

In the year 2023, Xiangxue Pharmaceutical Co distributed 0 CNY as dividends.

In which currency does Xiangxue Pharmaceutical Co pay out the dividend?

The dividends of Xiangxue Pharmaceutical Co are distributed in CNY.

Xiangxue Pharmaceutical Co Ticker	Xiangxue Pharmaceutical Co FIGI
300147:CH	BBG0018L1000
300147:CS	BBG0018R7FW3
300147:C2	BBG00F13B4V3

Own the gold standard ✨ in financial data & analytics fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Price

Price

Ticker300147.SZ

ISINCNE100000Y92

Xiangxue Pharmaceutical Co stock price

Price

Overview

Intraday Feature

Total Return and Relative Price Change

Interpretation and Investment

Xiangxue Pharmaceutical Co Stock Price History

Xiangxue Pharmaceutical Co Revenue, EBIT, Net Income CNE100000Y92 ·

Revenue, EBIT and Profit

Understanding Revenue, EBIT, and Income

Yearly Analysis and Comparisons

Utilizing Expectations for Investment

Investment Insights

Xiangxue Pharmaceutical Co Revenue, EBIT and net profit per share

Xiangxue Pharmaceutical Co Income Statement, Balance Sheet, Cash Flow Statement

Keystats

Revenue and Growth

Gross Margin

EBIT and EBIT Margin

Income and Growth

Shares Outstanding

Interpreting Year to Year Comparison

Expectations and Predictions

Balance Sheet

Understanding the Balance Sheet

Assets

Liabilities

Equity

Year-to-Year Analysis

Interpreting the Data

Xiangxue Pharmaceutical Co stock margins CNE100000Y92 ·

Margin

Understanding Gross Margin

EBIT Margin Analysis

Revenue Margin Insights

Interpreting Expectations

Comparative Analysis

Xiangxue Pharmaceutical Co Margin History

Xiangxue Pharmaceutical Co Stock Sales Revenue, EBIT, Earnings per Share CNE100000Y92 ·

Revenue, EBIT and Earnings per share

Revenue Per Share

EBIT Per Share

Income Per Share

Expected Values

Xiangxue Pharmaceutical Co Revenue, EBIT and net profit per share

Xiangxue Pharmaceutical Co business model

Xiangxue Pharmaceutical Co SWOT Analysis

Strengths

Weaknesses

Opportunities

Threats

Xiangxue Pharmaceutical Co Eulerpool Fair Value

Fair Value

Understanding Fair Value

Income-Based Fair Value

Revenue-Based Fair Value

Dividend-Based Fair Value

Expectations and Forecasts

Comparative Analysis

Xiangxue Pharmaceutical Co historical P/E ratio, EBIT, and P/S ratio.

Xiangxue Pharmaceutical Co shares outstanding CNE100000Y92 ·

Revenue, EBIT and Earnings per share

Revenue Per Share

EBIT Per Share

Income Per Share

Expected Values

Xiangxue Pharmaceutical Co Stock splits

Xiangxue Pharmaceutical Co dividend history and estimates CNE100000Y92 ·

Dividend

Dividend Overview

Interpretation and Use

Investment Strategy

Xiangxue Pharmaceutical Co Dividend History

Xiangxue Pharmaceutical Co dividend payout ratio CNE100000Y92 ·

Payout ratio

Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Ticker
300147.SZ

ISIN
CNE100000Y92